EUVIMEDEUVIMED entdecken
Crossref

Mechanisms and Efficacy of Mesenchymal Stem Cells in Progressive Pulmonary Fibrosis

Abai Baigenzhin, Alexey Pak, Zhanar Zarkumova, Lina Zaripova

Journal of Clinical Medicine of Kazakhstan · 08.09.2026 · 23 (5) · 81-93

DOI: 10.23950/jcmk/19232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine of Kazakhstan, erschienen am 08.09.2026. Verfasst von Abai Baigenzhin und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Progressive pulmonary fibrosis (PPF) is a clinical phenotype characterized by worsening fibrosis, declining lung function, and progressive respiratory symptoms despite appropriate treatment of the underlying interstitial lung disease (ILD). It may develop in several fibrotic ILDs other than idiopathic pulmonary fibrosis, including fibrotic hypersensitivity pneumonitis, nonspecific interstitial pneumonia, and connective tissue disease-associated ILD. PPF is associated with irreversible structural lung damage, reduced quality of life, and increased mortality. Despite the development of standard antifibrotic agents, specifically nintedanib and pirfenidone, therapeutic failure and disease progression remain common outcomes. Consequently, mesenchymal stromal cells (MSCs) represent a promising therapeutic approach due to their immunomodulatory, anti-inflammatory, and antifibrotic properties. This review evaluates the rationale for MSC-based therapy in fibrotic lung disease, summarizes available preclinical and clinical evidence, and discusses the limitations, safety considerations, and research priorities that must be addressed before clinical application can be established.

Zitieren

APA

Baigenzhin, A., Pak, A., Zarkumova, Z., & Zaripova, L. (2026). Mechanisms and Efficacy of Mesenchymal Stem Cells in Progressive Pulmonary Fibrosis. Journal of Clinical Medicine of Kazakhstan, 23(5), 81-93. https://doi.org/10.23950/jcmk/19232

Vancouver

Baigenzhin A, Pak A, Zarkumova Z, Zaripova L. Mechanisms and Efficacy of Mesenchymal Stem Cells in Progressive Pulmonary Fibrosis. Journal of Clinical Medicine of Kazakhstan. 2026;23(5):81-93. doi:10.23950/jcmk/19232

BibTeX
@article{Baigenzhin2026,
  author = {Baigenzhin, Abai and Pak, Alexey and Zarkumova, Zhanar and Zaripova, Lina},
  title = {Mechanisms and Efficacy of Mesenchymal Stem Cells in Progressive Pulmonary Fibrosis},
  journal = {Journal of Clinical Medicine of Kazakhstan},
  year = {2026},
  volume = {23},
  number = {5},
  pages = {81--93},
  doi = {10.23950/jcmk/19232}
}
Kostenlos starten →